Description:

CALGB: 80405 ADVERSE EVENT (AE) FORM NCT00265850 Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F39BC806-6212-58D3-E034-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F39BC806-6212-58D3-E034-0003BA3F9857

Keywords:
Versions (4) ▾
  1. 8/27/12
  2. 1/8/15
  3. 1/9/15
  4. 6/21/15
Uploaded on:

June 21, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

CALGB: 80405 ADVERSE EVENT (AE) FORM NCT00265850

INSTRUCTIONS: Complete and submit this form as required by the protocol. Information in the upper right box must be completed for this form to be accepted.

Header
Are data amended
Patient demographics
Expected Adverse Events
Has an AdEERS been filed (with Central Office based on an event reported below?)
CTC AE Attribution Code

Similar models